GRIP1 — Glutamate Receptor Interacting Protein 1

GRIP1 — Glutamate Receptor Interacting Protein 1

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GRIP1 — Glutamate Receptor Interacting Protein 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GRIP1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GRIP1 — Glutamate Receptor Interacting Protein 1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=GRIP1" target="_blank">Search NCBI</a></td>
</tr>
</table>

Grip1 — Glutamate Receptor Interacting Protein 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@dlgap2024]
title: GRIP1 Gene [@grip2023]
description: Glutamate Receptor Interacting Protein 1 gene implicated in neurodegenerative diseases [@ampa2023]
tags: gene, neurodegeneration [@grip2022]

--- [@postsynaptic2022]

.infobox.inbox-gene [@pdz2021]
GRIP1 [@therapeutic2021]
=== ===
Full Name: Glutamate Receptor Interacting Protein 1
Chromosome: 7q31.3
NCBI Gene ID: 9439
OMIM: 604697
Ensembl ID: ENSG00000155966
UniProt: O75177
=== ===
Associated Diseases: Autism spectrum disorder, intellectual disability, epilepsy, Alzheimer's disease, Parkinson's disease

Overview

GRIP1 — Glutamate Receptor Interacting Protein 1

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GRIP1 — Glutamate Receptor Interacting Protein 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>GRIP1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>GRIP1 — Glutamate Receptor Interacting Protein 1</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=GRIP1" target="_blank">Search NCBI</a></td>
</tr>
</table>

Grip1 — Glutamate Receptor Interacting Protein 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@dlgap2024]
title: GRIP1 Gene [@grip2023]
description: Glutamate Receptor Interacting Protein 1 gene implicated in neurodegenerative diseases [@ampa2023]
tags: gene, neurodegeneration [@grip2022]

--- [@postsynaptic2022]

.infobox.inbox-gene [@pdz2021]
GRIP1 [@therapeutic2021]
=== ===
Full Name: Glutamate Receptor Interacting Protein 1
Chromosome: 7q31.3
NCBI Gene ID: 9439
OMIM: 604697
Ensembl ID: ENSG00000155966
UniProt: O75177
=== ===
Associated Diseases: Autism spectrum disorder, intellectual disability, epilepsy, Alzheimer's disease, Parkinson's disease

Overview

Glutamate Receptor Interacting Protein 1 (GRIP1) is a critical postsynaptic scaffolding protein that plays essential roles in the trafficking, anchoring, and signaling of AMPA-type glutamate receptors at excitatory synapses. GRIP1 contains seven PDZ domains that serve as modular protein-protein interaction modules, enabling it to organize large macromolecular complexes at the postsynaptic membrane. The protein is fundamentally important for synaptic plasticity, learning, and memory, and its dysfunction has been implicated in both neurodevelopmental and neurodegenerative disorders.

Gene Structure

The GRIP1 gene spans approximately 120 kb on chromosome 7q31.3 and contains 29 exons encoding a protein of 1,112 amino acids with a molecular weight of approximately 120 kDa. The gene undergoes extensive alternative splicing, producing multiple isoforms with distinct expression patterns and binding properties. The protein's structure is characterized by multiple PDZ domains arranged in tandem, each capable of binding specific target proteins containing PDZ-binding motifs at their C-termini. The N-terminal region contains a phospholipid-binding domain that may target the protein to specific membrane compartments.

Protein Structure and Function

GRIP1 functions as a master scaffold protein at excitatory synapses, organizing AMPA receptor complexes and linking them to downstream signaling pathways. The protein's seven PDZ domains mediate interactions with: (1) AMPA receptor subunits GluA1, GluA2, and GluA3 through their C-terminal PDZ-binding motifs; (2) other scaffolding proteins including DLGAP1 and GRIP2; (3) cytoskeletal proteins including microtubules and actin-binding proteins; (4) signaling enzymes including Raf kinases and GRIP-associated binding proteins.

The primary functions of GRIP1 include: (1) anchoring AMPA receptors at the postsynaptic membrane during development and synaptic plasticity; (2) facilitating AMPA receptor recycling through interactions with endocytic machinery; (3) coordinating AMPA receptor signaling with downstream kinase and phosphatase pathways; (4) stabilizing synaptic contacts through interactions with the actin cytoskeleton; (5) regulating the subunit composition of synaptic AMPA receptors.

Expression Pattern

GRIP1 exhibits highest expression in brain regions associated with learning and memory, including the cerebral [cortex](/brain-regions/cortex) (layers II-VI), [hippocampus](/brain-regions/hippocampus) (CA1-CA3 pyramidal cells and dentate gyrus granule cells), basolateral amygdala, and cerebellar Purkinje cells. The protein is localized to postsynaptic densities of excitatory synapses on [dendritic spines](/cell-types/dendritic-spines). GRIP1 expression peaks during synaptogenesis in early development and maintains high levels in adulthood, consistent with its role in synaptic maintenance and plasticity.

Role in Neurodegeneration

Alzheimer's Disease: GRIP1 protein levels are reduced in Alzheimer's disease brain tissue, particularly in the hippocampus and prefrontal cortex. This reduction correlates with synaptic loss and cognitive decline. GRIP1 dysfunction may contribute to [amyloid-beta](/proteins/amyloid-beta)-induced synaptic dysfunction through disruption of AMPA receptor trafficking and plasticity.

Parkinson's Disease: Altered GRIP1 expression and phosphorylation have been observed in Parkinson's disease models. The protein's role in synaptic plasticity at corticostriatal synapses may be particularly relevant to dopaminergic dysfunction in Parkinson's disease.

Neurodevelopmental Disorders: GRIP1 mutations and copy number variations are associated with autism spectrum disorder, intellectual disability, and epilepsy. These disorders share mechanistic features with neurodegeneration including synaptic dysfunction and abnormal protein aggregation.

Therapeutic Implications

GRIP1 represents a promising therapeutic target for synaptic disorders. Potential approaches include: (1) small molecules that enhance GRIP1 expression or stabilize its interactions with AMPA receptors; (2) peptides mimicking GRIP1 PDZ domains to competitively inhibit pathological protein interactions; (3) gene therapy to restore GRIP1 levels in affected brain regions; (4) modulation of GRIP1 phosphorylation by downstream kinases.

Animal Models

Mouse Grip1 knockout is embryonic lethal, indicating essential developmental functions. Conditional knockout mice lacking Grip1 in forebrain [neurons](/entities/neurons) exhibit: severe deficits in AMPA receptor trafficking; impaired [long-term potentiation](/mechanisms/long-term-potentiation) and depression; abnormal dendritic spine morphology; deficits in spatial learning and memory; autism-like social behavior deficits. Transgenic overexpression of GRIP1 enhances synaptic plasticity and memory in mouse models.

Key Publications

[1] https://pubmed.ncbi.nlm.nih.gov/9288085/
[2] https://pubmed.ncbi.nlm.nih.gov/10652266/
[3] https://pubmed.ncbi.nlm.nih.gov/10893236/
[4] https://pubmed.ncbi.nlm.nih.gov/11891228/
[5] https://pubmed.ncbi.nlm.nih.gov/14627657/
[6] https://pubmed.ncbi.nlm.nih.gov/14638859/
[7] https://pubmed.ncbi.nlm.nih.gov/20052766/
[8] https://pubmed.ncbi.nlm.nih.gov/26581475/

See Also

• [Genes Index](/genes)
• [GRIP1 Protein](/proteins/grip1-protein)
• [DLGAP1 Protein](/proteins/dlgap1-protein)
• [AMPA Receptor Pathway](/mechanisms/synaptic-dysfunction-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/9439)
• [UniProt](https://www.uniprot.org/uniprot/O75177)
• [Ensembl](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000155966)
• [GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRIP1)

Background

The study of Grip1 — Glutamate Receptor Interacting Protein 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Allen Brain Atlas Resources

The Allen Brain Atlas provides comprehensive gene expression data across brain regions and cell types.

• [Allen Human Brain Atlas](https://human.brain-map.org/) — Gene expression data across the adult human brain
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — Gene expression in mouse brain
• [Allen Cell Type Atlas](https://celltypes.brain-map.org/) — Single-cell transcriptomics data
• [Allen Brain Map Portal](https://portal.brain-map.org/) — Access to all Allen Institute brain data

• [Human Brain Atlas search for GRIP1](https://human.brain-map.org/microarray/search/show?search_term=GRIP1)
• [Mouse Brain Atlas search for GRIP1](https://mouse.brain-map.org/search/index.html?query=GRIP1)

References